论文部分内容阅读
目的比较3种不同药物治疗产妇产后出血的治疗效果。方法将90例产后出血患者随机分为A、B、C 3组各30例。A组患者在胎儿前肩娩出后立即向患者子宫体内注射缩宫素,B组患者口服米索前列醇药物,C组患者则肌内注射卡前列素(欣母沛),比较3组产妇的治疗效果及不良反应发生情况。结果 B组及C组的总有效率为高于A组,且C组总有效率高于B组;B组及C组的不良反应发生率均高于A组,差异均有统计学意义(P<0.05)。结论欣母沛药物用于治疗产后出血疗效优于米索前列醇及缩宫素,而米索前列醇药物的治疗效果又优于缩宫素。虽欣母沛及米索前列醇药物治疗产后出血后的不良反应发生率高于缩宫素,但经适当处理后即可缓解。因此在治疗产妇产后出血时,应结合患者病情选择适当的治疗方法,以减少产后出血量,减少了产后出血的发生。
Objective To compare the therapeutic effects of three different drugs on postpartum hemorrhage. Methods 90 patients with postpartum hemorrhage were randomly divided into A, B, C 3 group of 30 cases. A group of patients in the anterior fetal shoulder immediately after delivery of oxytocin to the patient’s uterus, B group of patients taking oral misoprostol, C group intramuscular injection of carboprost (Yan Xin Pei), compared with three groups of maternal Treatment and adverse reactions occurred. Results The total effective rate of group B and C was higher than that of group A, and the total effective rate of group C was higher than that of group B. The incidence of adverse reactions in group B and C were higher than that of group A P <0.05). Conclusions Hermione drug is superior to misoprostol and oxytocin for the treatment of postpartum hemorrhage, and the therapeutic effect of misoprostol is superior to oxytocin. Although Xin Maopei and misoprostol drug treatment of postpartum hemorrhage adverse reactions than oxytocin, but after appropriate treatment can be alleviated. Therefore, in the treatment of postpartum hemorrhage, should be combined with the patient’s condition to select the appropriate treatment to reduce the amount of postpartum hemorrhage and reduce the incidence of postpartum hemorrhage.